Search results for "therapeutic combination"

showing 1 items of 1 documents

R-Rescovitine (Seliciclib) inhibits DNA damage-induced Cyclin A1 up-regulation and hinders non-homologous end joining: a rationale for therapeutic co…

2011

Settore MED/06 - Oncologia Medicahinders non-homologous end joiningtherapeutic combinationR_Rescovitine inhibits DNA damage-induced Cyclin A1 up-regulation
researchProduct